Some extra color on CVS Q1 results

Revenues: $32.7B (+6.3%): Pharmacy Services: $20.2B (+10.3%) generic dispensing rate: 82.4% (+2.4%), Retail Pharmacy: $16.5B (+2.7%) generic dispensing rate: 82.9% (+ 2.1%).

Net income: $1.1B (+18.3%), EPS: $0.95 (+23.3%).

Retail pharmacy same store prescription volumes: +2.1%.

Retail pharmacy same store sales: +1.4%.

CF Ops: $2.2B (+34.1%).

Q2 guidance:

EPS: $1.01 $1.04.

2014 guidance:

EPS: $4.09 - $4.23.

CF Ops: $7.0B - $7.3B.


From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs